Verudoxi
Oct 16, 2:41 PM
$LRMR
It seems likely that it will go to test the 1.6 to 1.8 support range by the end of October.
Information void
Unfulfilled promises
Tax-Loss Harvesting
Lack of momentum
Small-cap biotech weakness since mid-August
It’s a great stock, but the lack of buying at key support shows the market finds it unappealing. Based on the Investor Event, the BLA will likely be submitted between late November and early December... Still, management's recent response is deeply disappointing.
1 replies
